Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Further Update on Fundraise & Reorganisation

13th Mar 2026 07:00

RNS Number : 4662W
BSF Enterprise PLC
13 March 2026
 

13 March 2026

 

BSF Enterprise PLC

("BSF" or the "Company")

 

Further Update on Proposed £15m Equity Fundraise and Capital Reorganisation

 

Further to the Company's announcement on 27 February 2026 the Company provides an update on the previously announced Equity Fundraise and Capital Reorganisation. Capitalised terms used in this announcement have the same meanings as in the earlier announcement unless the context requires otherwise.

 

The Equity Fundraise for £15m and proposed Capital Reorganisation has been mutually terminated between the parties and each party will seek to terminate all relevant agreements that formed part of the transaction.

 

However the CLN of £300K will continue on the same terms but be extend for 12 months and then repaid in cash or the CLN noteholders have a right to convert over that period at next BSF capital raise price.

 

Further to the above, the Company confirms that it will seek alternative fundraising options and it has entered discussions with other parties to raise funds both at Group level and subsidiary level for Lab-grown Leather Ltd and Kerato Ltd.

 

This process remains ongoing and the Company is seeking to close a new favourable fundraising option in the coming weeks. The Company will provide further updates as appropriate.

 

 

END

 

Engage with the BSF Enterprise management team directly by asking questions, watching videosummaries and seeing what other shareholders have to say. Navigate to our Interactive Investorwebsite here:

 

https://bsfenterprise.com/link/ya3gRr

 

For further enquiries, please visit www.bsfenterprise.com or contact:

 

BSF Enterprise PLC

Geoff Baker - Chairman

Che Connon - CEO & Director

 

We encourage all investors to share questions on this announcement via our investor website.

https://bsfenterprise.com/s/a1f22b

Shard Capital (Broker)

Damon Heath

Isabella Pierre

 

(0)20 4530 6926

(0)20 4530 6928

AlbR Capital Limited (Broker)

Colin Rowbury

Jon Belliss

+44 (0)20 7469 0930

ISIN of the Ordinary Shares

is GB00BHNBDQ51.

SEDOL Code is BHNBDQ5.

 

 

Subscribe to our news alert service: https://bsfenterprise.com/s/bb9f43

 

About BSF Enterprise PLC

BSF Enterprise PLC (BSF) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free platform, BSF aims to deliver sustainable alternatives to traditional materials and meet global demand for environmentally responsible innovations.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAKBBQPBKDNND

Related Shares:

Bio-Sustainable Future Enterprises
FTSE 100 Latest
Value10,097.58
Change34.08